Allen Feng

Dr. Allen Feng is the co-founder and Chief Scientific Officer of HebeCell Corp. Prior to HebeCell, Dr. Feng was the Director of Cell Biology of Semma Therapeutics (Now Vertex Therapeutics). Before Semma, Dr. Feng worked as R&D Head of Stem Cell Bioprocessing Group at EMD Millipore (a US subsidiary of Merck, KGaA). Prior to Merck Millipore, Dr. Feng was Director and Senior Scientist at Advanced Cell Technology (later became Ocata Therapeutics and Astellas). Dr. Feng was the inventor of several key patents describing methods of generating various types of hematopoietic cells using human pluripotent stem cells.